Based in Ahmedabad, India, CPL Biologicals Pvt. Ltd. is a joint-venture biotechnology company established in 2009 by Novavax Inc., USA and Cadila Pharmaceuticals Limited, one of India's largest privately held pharmaceutical companies. CPL Biologicals has a three pronged approach to providing novel, affordable solution for global healthcare - Vaccines, Biologics and Diagnostics, with integrated capabilities from early stage research and development to clinical and commercial manufacturing along with dedicated sales and marketing teams. CPL Biologicals has established state-of-the-art R&D and manufacturing facilities in Dholka, Ahmedabad, which currently has the capability of producing up to 25 million doses every year. Vision To be a leading provider of high quality, affordable vaccines, biologics and diagnostics through world-class research and innovations combined with cost effective and efficient manufacturing to address current and future global health challenges. Mission: We will discover, develop and successfully market Biological products to diagnose, prevent and cure diseases. We shall provide total customer satisfaction and achieve leadership in chosen markets, products and services across the globe, through excellence in technology, based on world-class research and development. We are responsible to the society. We shall be good corporate citizens and will be driven by high ethical standards in our practices.
Based in Ahmedabad, India, CPL Biologicals Pvt. Ltd. is a joint-venture biotechnology company established in 2009 by Novavax Inc., USA and Cadila Pharmaceuticals Limited, one of India's largest privately held pharmaceutical companies. CPL Biologicals has a three pronged approach to providing novel, affordable solution for global healthcare - Vaccines, Biologics and Diagnostics, with integrated capabilities from early stage research and development to clinical and commercial manufacturing along with dedicated sales and marketing teams. CPL Biologicals has established state-of-the-art R&D and manufacturing facilities in Dholka, Ahmedabad, which currently has the capability of producing up to 25 million doses every year. Vision To be a leading provider of high quality, affordable vaccines, biologics and diagnostics through world-class research and innovations combined with cost effective and efficient manufacturing to address current and future global health challenges. Mission: We will discover, develop and successfully market Biological products to diagnose, prevent and cure diseases. We shall provide total customer satisfaction and achieve leadership in chosen markets, products and services across the globe, through excellence in technology, based on world-class research and development. We are responsible to the society. We shall be good corporate citizens and will be driven by high ethical standards in our practices.